AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tonyt who wrote (493)	8/18/1997 10:18:00 PM
From: Andrew H	of 2173

Tony, I am not speaking of any large houses in particular. I don't follow AMLN that closely anymore. I am speaking in generalities. I assume there are at least a couple of larger firms covering AMLN. I could be wrong. Everon is not that large. My point is that if say, Alex Brown and Merrill Lynch or H and Q were to downgrade (if in fact they cover at all), the stock price could go lower. It is all hypothetical. Just speculating on possiblities. Actually, the price rebounded a bit later in the day and could rebound more. I am just urging caution. I am thinking pretty much along the lines David is on this one. The next P3 trials should tell us a lot more.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next